
Early prostate cancer usually causes no symptoms, so men over 50 should ask a doctor about PSA testing.
The prostate — a walnut-sized gland just below the bladder in men — is not something most Indian men think about until something goes wrong. Yet prostate-related conditions affect the majority of men at some point, with the most common (benign prostatic hyperplasia) affecting more than 50% of men by age 60 and up to 90% by age 80.
Three distinct conditions affect the prostate, and they produce overlapping symptoms that require medical evaluation to distinguish. Understanding them — and recognising when symptoms warrant investigation — is genuinely valuable health knowledge for Indian men approaching middle age.
BPH is non-cancerous enlargement of the prostate — the gland grows larger with age through a hormonally driven process. Because the prostate surrounds the urethra (the tube carrying urine from the bladder), enlargement compresses it, causing urinary symptoms that progressively worsen if untreated.
BPH is not cancer and does not increase cancer risk — the two conditions are separate. But its symptoms significantly impair quality of life.
Symptoms of BPH:
Obstructive symptoms (from the enlarged gland blocking the urethra):
Irritative (storage) symptoms (from the bladder working harder to overcome obstruction):
Severity scoring: the International Prostate Symptom Score (IPSS) is a standardised questionnaire that quantifies symptom severity. Mild (0–7), moderate (8–19), and severe (20–35). Many urologists use this score to guide treatment decisions.
Complications of untreated severe BPH:
Prostatitis is inflammation of the prostate — affecting men of all ages, unlike BPH which is primarily age-related.
Types:
Acute bacterial prostatitis: sudden onset, usually from a bacterial infection. Produces:
This is a medical urgency — requires antibiotic treatment (typically fluoroquinolones for 4–6 weeks; hospitalisation and IV antibiotics for severe cases).
Chronic bacterial prostatitis: recurring urinary infections with the prostate as the reservoir. Lower-grade symptoms than acute — pelvic discomfort, mild urinary symptoms, recurrent UTI-like episodes. Long-course antibiotics (6–12 weeks) are typically needed.
Chronic pelvic pain syndrome (CPPS): the most common type of prostatitis, accounting for 90% of cases. Characterised by pelvic, perineal, or genital pain lasting more than 3 months, with or without urinary symptoms. No bacterial infection is identified.
CPPS causes significant suffering — chronic pain affects quality of life, causes anxiety and depression, and is often mismanaged. Treatment is multi-modal: alpha-blockers (relax smooth muscle), anti-inflammatories, pelvic floor physiotherapy (a specialist physio can significantly reduce symptoms), and sometimes nerve-modulating medications.
Prostate cancer is less common in Indian men than in men of African heritage or Western Caucasian men — India's overall prostate cancer rates are among the lower globally. However, incidence is rising in urban India as dietary and lifestyle patterns change, and the implications of a late diagnosis are serious.
Prostate cancer is typically slow-growing — many men die with prostate cancer rather than from it. But high-grade prostate cancers (Gleason 8–10) can be aggressive and require prompt treatment.
Early-stage prostate cancer has no symptoms. This is the critical point. The early-stage, most curable form of prostate cancer is silent — it doesn't cause pain, urinary symptoms, or any alert. This is why screening (PSA testing) matters: it detects prostate cancer in its silent, treatable phase.
Symptoms suggesting advanced or locally advanced prostate cancer:
PSA (Prostate Specific Antigen): a blood test that measures a protein produced by prostate cells. Elevated PSA suggests prostate pathology — which may be BPH, prostatitis, or cancer. PSA is not a cancer diagnosis test; it is a screening signal that triggers further evaluation.
When to consider PSA screening:
A PSA result must be interpreted alongside digital rectal examination (DRE) findings, rate of PSA rise (PSA velocity), and clinical context. Isolated mildly elevated PSA has many causes and doesn't automatically mean cancer — but persistent elevation or rapid rise warrants urology referral.
See a doctor if you experience:
History and IPSS score: quantifying symptom severity guides decisions.
Physical examination including DRE (digital rectal examination): a doctor inserts a gloved finger into the rectum to palpate the posterior surface of the prostate. This assesses prostate size, consistency, and symmetry. Uncomfortable but brief; important information not available any other way.
PSA blood test: for appropriate age groups, with informed consent about what the test implies and the potential for further investigation.
Uroflowmetry: the patient urinates into a flow meter — measures flow rate and voided volume. Objective measure of obstructive urinary symptoms.
Post-void residual ultrasound: a quick ultrasound scan of the bladder immediately after urinating measures how much urine is retained — important for assessing obstruction severity.
Urine culture: to rule out infection contributing to symptoms.
Transrectal ultrasound (TRUS) and biopsy: if PSA or DRE raises concern for cancer, a urologist performs a biopsy under ultrasound guidance to sample the prostate. Results confirm cancer and provide Gleason grading.
MRI of the prostate (mpMRI): increasingly used before biopsy to identify suspicious areas — reduces unnecessary biopsies and improves biopsy targeting.
BPH (mild symptoms): watchful waiting with lifestyle modification — reduce caffeine and alcohol (both worsen urinary symptoms), avoid large fluid volumes before bed, time fluid intake away from sleep.
BPH (moderate-severe symptoms): alpha-blockers (tamsulosin, alfuzosin — relax smooth muscle of the prostate and urethra, improving flow within days), 5-alpha reductase inhibitors (finasteride, dutasteride — shrink the prostate over months), or combination therapy. Surgical options (TURP — transurethral resection of the prostate) for severe or complicated BPH.
Prostatitis (bacterial): long-course antibiotics; pelvic floor physiotherapy for CPPS.
Prostate cancer: managed based on stage and grade — active surveillance (watchful waiting for low-grade), surgery (radical prostatectomy), radiotherapy, hormonal therapy (androgen deprivation for advanced disease). Requires specialist oncology and urology involvement.
At Prakash Hospital Noida, our physicians and urologists evaluate prostate symptoms — including PSA testing, uroflowmetry, post-void residual ultrasound, and urology referral for appropriate investigation and management.
Whether you live in Sector 18, Sector 62, Greater Noida West, or anywhere in the NCR, Prakash Hospital Noida is a trusted name for prostate health, urology, and men's health in Noida.
To book a consultation, call the number.
Tags: #ProstateSymptoms #ProstateHealthIndia #PrakashHospitalNoida
This article covers urology concerns. These Prakash Hospital doctors in Noida treat them.
We offer expert care across key specialties, including Medicine, Cardiology, Orthopaedics, ENT, Gynaecology, and more—delivering trusted treatment under one roof.


Book a consultation with Prakash Hospital's specialists — 24/7 emergency care, 100+ doctors, NABH accredited.
Prakash Hospital Pvt. Ltd. is a 100 bedded NABH NABL accredited multispecialty hospital along with a center of trauma and orthopedics. We are in the service of society since 2001.
OUR SPECIALITIES
Patient Services
PROCEDURES
Contact Us
D – 12A, 12B, Sector-33, G. B. Nagar, Noida, Uttar Pradesh 201301
+91-8826000033

© 2026 All rights reserved.
Designed and Developed by Zarle Infotech